Mercer Global Advisors
LLY icon

Mercer Global Advisors’s Eli Lilly LLY Stock Holding History

Mercer Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161M Buy
175,063
+40,673
+30% +$41.2M 0.24% 54
2025
Q4 		$149M Buy
134,390
+7,890
+6% +$7.54M 0.23% 59
2025
Q3 		$95.1M Buy
+126,500
New +$94.1M 0.16% 83
2025
Q2 		– Sell
-112,315
Closed -$87.3M – 2324
2025
Q1 		$91.3M Buy
112,315
+731
+0.7% +$608K 0.21% 66
2024
Q4 		$84.8M Sell
111,584
-591,250
-84% -$490M 0.21% 69
2024
Q3 		$622M Buy
702,834
+8,774
+1% +$7.89M 1.45% 18
2024
Q2 		$628M Buy
694,060
+2,681
+0.4% +$2.14M 1.71% 15
2024
Q1 		$538M Sell
691,379
-8,109
-1% -$5.77M 1.53% 16
2023
Q4 		$408M Buy
699,488
+597,436
+585% +$349M 1.23% 18
2023
Q3 		$54.8M Sell
102,052
-3,498
-3% -$1.8M 0.21% 73
2023
Q2 		$49.5M Buy
105,550
+17,434
+20% +$7.31M 0.2% 80
2023
Q1 		$30.3M Buy
88,116
+2,112
+2% +$712K 0.14% 114
2022
Q4 		$31.5M Buy
86,004
+8,573
+11% +$3.04M 0.16% 100
2022
Q3 		$25M Buy
77,431
+846
+1% +$268K 0.15% 109
2022
Q2 		$24.8M Buy
76,585
+6,980
+10% +$2.1M 0.15% 107
2022
Q1 		$19.9M Buy
69,605
+7,716
+12% +$1.99M 0.12% 135
2021
Q4 		$17.1M Buy
61,889
+847
+1% +$215K 0.11% 150
2021
Q3 		$14.1M Sell
61,042
-2,356
-4% -$581K 0.1% 170
2021
Q2 		$14.6M Buy
63,398
+11,698
+23% +$2.35M 0.11% 143
2021
Q1 		$9.66M Buy
51,700
+4,773
+10% +$934K 0.09% 180
2020
Q4 		$7.92M Buy
46,927
+4,475
+11% +$668K 0.1% 157
2020
Q3 		$6.28M Buy
42,452
+3,798
+10% +$588K 0.09% 165
2020
Q2 		$6.35M Buy
38,654
+1,727
+5% +$265K 0.12% 132
2020
Q1 		$5.12M Buy
36,927
+9,001
+32% +$1.24M 0.11% 158
2019
Q4 		$3.67M Buy
27,926
+199
+0.7% +$23.1K 0.07% 218
2019
Q3 		$3.1M Buy
27,727
+478
+2% +$53.2K 0.07% 216
2019
Q2 		$3.02M Sell
27,249
-9,821
-26% -$1.16M 0.08% 203
2019
Q1 		$4.81M Buy
+37,070
New +$4.51M 0.17% 109

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mercer Global Advisors's LLY Position: Q1 2026 in Review

Mercer Global Advisors increased its Eli Lilly (LLY) stake by 30% in Q1 2026, buying an estimated $41.2M and bringing the position to 175,063 shares worth $161M. The position accounts for 0.24% of the portfolio, ranked #54.

Mercer Global Advisors first reported a position in LLY in Q1 2019 and has held it in 28 quarters since. The position peaked at $628M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mercer Global Advisors held 175,063 shares of Eli Lilly worth $161M as of Q1 2026.
  • Mercer Global Advisors bought 40,673 Eli Lilly shares in Q1 2026, an estimated $41.2M.
  • Eli Lilly made up 0.24% of Mercer Global Advisors's portfolio in Q1 2026, its #54 holding.
  • Mercer Global Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 28 quarters since.
  • Mercer Global Advisors's Eli Lilly position peaked at $628M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.